📌The #ThinkNENs program is designed to empower PCPs with the knowledge to recognize NENs and refer NEN patients earlier.
• Free, online & CME-accredited
• Available in 7 languages
• Endorsed by top NEN societies
✅Start today: incalliance.org/think-nens/
#LetsTalkAboutNETs

💡 Just presented our abstract at the @netrf.org Medical Symposium 2025!

Our data from the ancora.ai #NET Digital Trial Finder exposed a critical breakdown in patient recruitment.

The issue? Patient interest is strong, but the follow-up process is failing them.
#ClinicalTrials #NeuroEndocrineTumors

Ancora.ai was honored to have attended the 1st-ever World #CUP Alliance meeting yesterday in Berlin!

The meeting was an inspiring day full of incredible research & collaboration focused on improving the lives of patients with Cancer of Unknown Primary (CUP).

#cancerunknownprimary

ICYMI: @danafarber.bsky.social's Patrick Wen, MD, spoke with @oncodaily.bsky.social On Air about the @fda.gov approval of Dordaviprone in H3K27M-mutated diffuse midline glioma.

Listen here: bit.ly/3KqeLMk

Our #braintumor #clinicaltrial finder tool is now live!

A huge thanks to our incredible expert group of #patient advocates, #physicians, researchers & #biotech as well as our collaborators 5P Health Care Solutions.

Link to tool www.ancora.ai/braintumors
Press release www.ancora.ai/en/newsartic...

Do you know how easy it is to quickly find a NEN clinical trial that fits your condition and is close to your location?
✅Try here: incalliance.org/find-a-trial/
#LetsTalkAboutNETs #NENClinicalTrials
@ancoraai.bsky.social

Our team was privileged to attend ICPO Foundation's forum- a fantastic gathering focused on the advancement of #radiopharmaceuticals in #oncology.

We're grateful for the opportunity to have presented our newly released Global Radiopharmaceutical Trial Finder powered by Ancora.ai
💫 www.radtrials.com

1/3 Excited to share two recent publications! 🧠💡 First, we explored radioligand target expression in high-grade #meningioma, finding #SSTR2a and #FAP variably expressed, with implications for patient selection and radioligand therapy design. @nathaliealbert.bsky.social doi.org/n786

Do you want to know what is happening in radioligand therapy for patients with neuroendocrine tumors? What is hot and what is not...? if so this team (which has not yet migrated over to BlueSky...) has you covered... 😀

onlinelibrary.wiley.com/doi/10.1111/...

Patient advocate @sunonmyhip.bsky.social joins #LungCancerConsidered host @narjustflorezmd.bsky.social to discuss her lung cancer journey & the power of advocacy groups. Learn about self-advocacy, patient-centered care & palliative care.

🎧 Listen now: bit.ly/PAGroups

#PatientAdvocacy

Professor @drjnaidoo.bsky.social welcomed to the #BTOG25 stage as a Lung Cancer Legend & doesn’t disappoint. Lots of discussion on how we turn discussions on Small Cell Lung Cancer on its head. Lots of optimism in #SCLC coming from new standards & future treatments. #LCSM

Radioligand therapy demonstrates improved clinical benefit in patients with gastroenteropancreatic neuroendocrine tumors vs. molecular targeted therapy. 

🔬 The results of #COMPETE trial were presented today by Jaume Capdevila, at the 22nd Annual Conference of #ENETS 👉 https://linke.to/COMPETEVHIO

David James spoke to Anna Jones at
@skynewsrss.bsky.social this morning with patient advocate Dee to discuss why we need urgent reform in how we diagnose prostate cancer. Too many men are being diagnosed too late - we must act now. It's time for a screening programme
www.youtube.com/watch?v=CdUB...

The Winn Career Development Award is open for applications! The 2-year program provides training and support for early-stage investigator physicians to improve participation in clinical trials. Details at winnawards.org. Apply by May 12, 2025. #WinnAwards #WinnCDA @drdonsdizon.bsky.social

Research-driven advances in cancer science have led to new treatments for the thousands of people diagnosed with rare cancers. Learn more on #RareDiseaseDay: cancerprogressreport.aacr.org/progress/cpr.... #CancerResearchSavesLives® #FundNIH

We're thrilled to announce the launch of the Brain Tumor Trial Finder project!

We're embarking on a mission to expand the Ancora.ai #clinicaltrial finder to include brain tumors.

Our goal is simple: make it easier for #braintumor patients to find & access clinical trials.